Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001513162-19-000156
Filing Date
2019-06-12
Accepted
2019-06-11 17:51:38
Documents
60
Period of Report
2019-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q form10q.htm 10-Q 907716
2 EXHIBIT 31.1 exhibit31_1.htm EX-31 15003
3 EXHIBIT 31.2 exhibit31_2.htm EX-31 14159
4 EXHIBIT 32.1 exhibit32_1.htm EX-32 7924
5 EXHIBIT 32.2 exhibit32_2.htm EX-32 8394
  Complete submission text file 0001513162-19-000156.txt   4462949

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT anix-20190430.xml EX-101.INS 992840
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anix-20190430.xsd EX-101.SCH 47368
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT anix-20190430_cal.xml EX-101.CAL 28130
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anix-20190430_def.xml EX-101.DEF 256515
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT anix-20190430_lab.xml EX-101.LAB 284317
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anix-20190430_pre.xml EX-101.PRE 246243
Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Filer) CIK: 0000715446 (see all company filings)

EIN.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 001-37492 | Film No.: 19891954
SIC: 8071 Services-Medical Laboratories